Darwin Global Management, Ltd. has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $586 Million distributed in 12 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vaxcyte, Inc. with a value of $188M, Nuvalent, Inc. with a value of $108M, Keros Therapeutics, Inc. with a value of $95.1M, Alpine Immune Sciences, Inc. with a value of $78.6M, and Beam Therapeutics Inc. with a value of $70M.

Examining the 13F form we can see an increase of $315M in the current position value, from $272M to 586M.

Darwin Global Management, Ltd. is based out at St. Helier, Y9

Below you can find more details about Darwin Global Management, Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $586 Million
Healthcare: $586 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 12
  • Current Value $586 Million
  • Prior Value $272 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 9 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Darwin Global Management, Ltd. Portfolio

Follow Darwin Global Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Darwin Global Management, Ltd. with notifications on news.